Cover Image
市場調查報告書

失眠症治療藥的全球市場:2015∼2019年

Global Insomnia Drug Market 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 339943
出版日期 內容資訊 英文 62 Pages
訂單完成後即時交付
價格
Back to Top
失眠症治療藥的全球市場:2015∼2019年 Global Insomnia Drug Market 2015-2019
出版日期: 2015年09月16日 內容資訊: 英文 62 Pages
簡介

失眠症有急性和慢性,急性失眠症的主要原因是工作相關的緊張狀態。另一方面慢性的失眠症,原因有關節病症等疾病、安非他命等藥物、古柯鹼等藥物。預計全球失眠症治療藥市場2014∼2019年以年複合成長率3.08%擴大。

本報告提供全球失眠症治療藥市場相關調查、市場現狀及至2019年的成長預測、市場規模、各市場區隔趨勢、各地區趨勢,及主要供應商簡介彙整。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 失眠症:概要

  • 簡介
  • 流行病學

第6章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 產品研發線

  • 開發平台候補藥的案例

第8章 各製劑市場區隔

  • 片劑
  • 膠囊
  • 噴霧

第9章 各症狀市場區隔

  • 市場概要
  • 品質差的睡眠
  • 睡眠開始/維持的困難
  • 其他

第10章 各地區市場區隔

  • 市場概要

第11章 推動市場的要素

第12章 促進要素的影響

第13章 市場課題

第14章 促進要素與課題的影響

第15章 市場趨勢

第16章 供應商環境

  • 競爭模式
  • 主要供應商:2014年
  • 其他值得注意的供應商

第17章 主要供應商分析

  • Eisai株式會社
  • Merck
  • Pfizer
  • Sanofi
  • 武田藥品工業株式會社

第18章 附錄

第19章 Technavio概要

圖表

目錄
Product Code: IRTNTR7188

About insomnia

Insomnia or sleeplessness is characterized by the difficulty in falling asleep or remaining asleep, resulting in poor quality of sleep or little sleep. Sleeplessness can be acute or chronic. Work-related stress is the more common factor for acute or primary insomnia, while medical conditions, such as arthritis, or medicines, such as amphetamines, and substances, such as cocaine, are the common factors for chronic insomnia.

Technavio's analysts forecast the global insomnia market to decline at a CAGR of 3.08% over the period 2014-2019.

Covered in this report

The report includes the present scenario and the growth prospects of the global insomnia market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used for the treatment of insomnia.

Technavio's report, Global Insomnia Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report includes a discussion of the key vendors operating in this market.

Key regions

  • Americas
  • APAC
  • EMEA

Key vendors

  • Eisai
  • Merck
  • Pfizer
  • Sanofi
  • Takeda

Other Prominent Vendors

  • Astellas
  • Biocodex
  • Dainippon Sumitomo
  • ECR Pharmaceuticals (Valeant)
  • Fidia Farmaceutici
  • Flynn Pharma
  • Johnson & Johnson
  • Juste
  • Meda

Key market driver

  • Unmet medical needs
  • For a full, detailed list, view our report

Key market challenge

  • Dominance of generic products
  • For a full, detailed list, view our report

Key market trend

  • Emerging drugs targeting orexin receptors
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Insomnia: An overview

  • Introduction
  • Epidemiology

PART 06: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 07: Pipeline portfolio

  • Examples of pipeline candidates

PART 08: Market segmentation by type of formulation

  • Tablets
  • Capsules
  • Mist formulation

PART 09: Market segmentation by symptom

  • Market overview
  • Poor-quality sleep
  • Difficulties with sleep onset and/or maintenance
  • Others

PART 10: Geographical segmentation

  • Market overview

PART 11: Market drivers

PART 12: Impact of drivers

PART 13: Market challenges

PART 14: Impact of drivers and challenges

PART 15: Market trends

PART 16: Vendor landscape

  • Competitive scenario
  • Market share analysis
  • Other prominent vendors

PART 17: Key vendor analysis

  • Eisai
  • Merck
  • Pfizer
  • Sanofi
  • Takeda

PART 18: Appendix

  • List of abbreviations

PART 19: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Global insomnia drugs market 2014-2019 ($ billions)
  • Exhibit 03: Key performance indicators of global insomnia drugs market
  • Exhibit 04: Five forces analysis
  • Exhibit 05: Pipeline portfolio
  • Exhibit 06: Market segmentation by type of formulation
  • Exhibit 07: Market segmentation by symptom
  • Exhibit 08: Geographical segmentation 2014
  • Exhibit 09: Global insomnia drugs market: Key drivers
  • Exhibit 10: Impact of drivers
  • Exhibit 11: Global insomnia drugs market: Key challenges
  • Exhibit 12: Impact of drivers and challenges
  • Exhibit 13: Global insomnia drugs market: Emerging trends
  • Exhibit 14: Lunesta sales in North America 2011-2014 ($ millions)
  • Exhibit 15: Lunesta sales in Japan 2013-2014 ($ millions)
  • Exhibit 16: Ambien: Global sales 2011-2014 ($ millions)
  • Exhibit 17: Ambien sales in Western Europe 2011-2014 ($ millions)
  • Exhibit 18: Ambien sales in the US 2011-2014 ($ millions)
  • Exhibit 19: Ambien sales in emerging markets 2011-2014 ($ millions)
  • Exhibit 20: Ambien sales in ROW 2011-2014 ($ millions)
  • Exhibit 21: Rozerem: Global sales 2011-2013 ($ millions)
  • Exhibit 22: Rozerem sales in Japan 2012-2014 ($ millions)
  • Exhibit 23: Takeda: Business segmentation by revenue 2015
  • Exhibit 24: Takeda: Business segmentation by revenue 2014 and 2015 ($ millions)
  • Exhibit 25: Takeda: Geographical segmentation by revenue 2015
Back to Top